How Does TheyaVue Work? Its Ingredient Groups

No clinical trial of TheyaVue itself exists. What follows is not a study of this capsule. It is a walk through five groups of ingredients on its panel, what each group is studied for in its own separate research, and whether the amount here plausibly reaches that research dose. Sometimes it does. More often, because the panel hides ten of the ingredients inside one 240.5 mg total, there is no way to know.

Treat every section below as two questions, not one: is there real research behind this ingredient, and does this particular bottle carry enough of it to matter. A yes to the first is not a yes to the second.

Zinc is a genuine part of eye research, not a marketing add-on. It is one of the six nutrients in the AREDS2 formula, tested at 80 mg a day, with a lower 25 mg arm added later after the AREDS trial began exploring smaller doses Age-Related et al., 2013. This label supplies 32 mg a day as zinc oxide, a form absorbed at roughly half the rate of zinc citrate or gluconate National Institutes of Health, 2026. That puts it between the two AREDS2 arms in raw milligrams, though the oxide form means less of it is actually taken up.

Copper rides along at 2 mg a day, and that number is an exact match for AREDS2. It is there for a specific, well-documented reason: zinc at this range can lower copper absorption enough to cause a deficiency, so a real zinc-and-eye formula pairs the two National Institutes of Health, 2026. On this one point, the label follows the research correctly.

Four of the blend's ten ingredients are flavonoids or flavonoid-rich extracts: quercetin, rutin, grape seed extract and the anthocyanins in bilberry. All four are antioxidants in a laboratory sense. Human eye evidence for each is thin and uneven.

Quercetin is usually studied at 500 to 1,000 mg a day for general antioxidant effects; a 2017 review of quercetin and the eye found 44 registered human trials and not one that tested an eye disease McKay et al., 2017. A separate safety review flagged a lack of long-term data above 1,000 mg Andres et al., 2018. This entire blend totals 481 mg a day, for ten ingredients combined.

Rutin's human evidence traces back to a 1948 case report on diabetic retinopathy, before modern trial standards existed, and a 2023 review notes rutin absorbs poorly from the gut in the first place Tobar-Delgado et al., 2023. Grape seed extract has one real randomized trial, 150 mg a day for a year, that improved one finding in diabetic retinopathy Moon et al., 2019. Bilberry's wartime night-vision story, tracing to a myth about RAF pilots, was reviewed and not supported by controlled trials Canter et al., 2004. Two more blend members, alpha lipoic acid and eyebright, have their own single studies: ALA at 600 mg a day did not prevent diabetic macular edema in a two-year trial, a dose larger than this whole blend Haritoglou et al., 2011, and eyebright's only controlled human trial tested homeopathic eye drops, not the oral capsule form used here Drugs.com et al., 2026. None of the six has a published amount on this label.